Name: Exagen Inc (XGN) News, Articles, Events & Latest Updates
Creator: Stocktwits

SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following positive news of UAE regulatory approval for its immunotherapy drug Anktiva, fueling community discussion about global expansion and the company's long-term commercial potential. Investors remain focused on the upcoming earnings report, debating the company's revenue growth trajectory against concerns over high cash burn and the ongoing short interest.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir Technologies is surging following an exceptional earnings report that featured massive revenue growth and increased full-year guidance, effectively fueling community sentiment and triggering aggressive upgrades from analysts. Investors are actively debating the company's valuation versus its AI-driven momentum, with many bulls calling for significant price appreciation as the stock breaks past previous resistance levels.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher Digital is trending as investors aggressively rotate back into AI infrastructure and energy-intensive data center stocks, buoyed by signals of sustained hyperscaler demand for compute capacity. The market is focusing on the company's progress in executing its buildout schedule and securing long-term contracts, which many in the community view as an essential hedge against broader market volatility.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending as investors weigh an upcoming earnings report that could signal a turnaround for the stock, with community sentiment divided between those betting on ad revenue growth and those concerned about persistent leadership and governance issues. Discussion is currently focused on whether the company's cost-cutting measures and new AI-driven ad features will finally trigger a sustained recovery or if the stock will continue to face volatility following recent performance trends.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing intense volatility driven by speculation over a potential U.S. government ban on Chinese optical transceivers, which investors see as a major catalyst for domestic suppliers to capture displaced market share. While some community members are betting on a massive breakout, others remain skeptical, warning of the stock's historical tendency for dilution and susceptibility to aggressive algorithmic trading.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing heightened investor interest and volatile price action as the community debates its role in the AI data center supply chain and the implications of potential U.S. restrictions on Chinese optical components. While some investors point to key leadership additions and a robust cash position as catalysts for a long-term breakout, others remain skeptical due to the lack of realized revenue and recurring downward price pressure.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is currently trending as investors debate whether the stock has hit a bottom, with sentiment heavily divided between those seeking deep value and those concerned by stiff competition in the athletic footwear space. Community discussions are centered on institutional accumulation patterns, skepticism toward analyst downgrades, and the long-term impact of the company's efforts to restructure its digital strategy in China.

Caterpillar, Inc. engages in the business of manufacturing construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives. It operates through the following segments: Construction Industries, Resource Industries, Power and Energy, and All Other. The Construction Industries segment is involved in supporting customers using machinery in infrastructure and building construction applications. The Resource Industries segment offers machinery in mining, heavy construction, quarry, and aggregates. The Power and Energy segment focuses on reciprocating engines, turbines, diesel-electric locomotives, and related services across industries serving oil and gas, power generation, industrial, and transportation applications including marine- and rail-related businesses. The All Other segment includes activities such as the business strategy, product management and development, manufacturing, and sourcing of wear and maintenance components products, parts distribution, integrated logistics solutions, distribution services responsible for dealer development, and administration. The company was founded on April 15, 1925, and is headquartered in Irving, TX.

Caterpillar Inc.

Caterpillar is surging following a record-breaking earnings report that surpassed estimates, driven by unprecedented demand for power-generation equipment to support AI data center expansion. The community is actively debating the sustainability of this AI-linked growth versus the risks of cyclical cooling, with intense focus on the stock's significant year-to-date performance and evolving role as an infrastructure-critical play.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is experiencing significant investor scrutiny following earnings that surpassed consensus estimates, yet the stock remains range-bound as shareholders express frustration over stagnant price action despite reaffirmed guidance and anticipated cost-savings. The community is actively debating the stock's defensive value and dividend reliability versus the impact of recent leadership decisions, while simultaneously speculating on potential M&A activity within the pharmaceutical sector.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is experiencing intense volatility as traders pivot between skepticism over repeated claims of diplomatic breakthroughs in the Strait of Hormuz and intensifying geopolitical conflict, including reported drone strikes on regional bases. Community discussion remains heavily polarized, with many retail participants accusing the administration of market manipulation via strategic reserve management while others highlight the growing decoupling between paper market narratives and the reality of tightening physical supply.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

How Much Upside is Left in Exagen (XGN)? Wall Street Analysts Think 73.05%

The average of price targets set by Wall Street analysts indicates a potential upside of 73.1% in Exagen (XGN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Exagen (XGN) Q1 2026 Earnings Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Exagen Q1 Earnings Call Highlights

The New Spec Supercycle

Momentum traders are once again crowding into emerging growth sectors as artificial intelligence infrastructure, defense modernization, advanced medical technologies, and digital asset finance combine to create one of the market’s most aggressive speculative environments in years. Several names touched new 52-week highs Monday morning alongside major technology leaders including NVIDIA (NASDAQ:NVDA). $ODYS, $KBLB, $DGXX, $BW, $XGN, $MEHA, $NVDA

Exagen Inc. (XGN) Reports Q1 Loss, Beats Revenue Estimates

Exagen (XGN) delivered earnings and revenue surprises of +29.17% and +4.57%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

AtriCure (ATRC) Reports Break-Even Earnings for Q1

AtriCure (ATRC) delivered earnings and revenue surprises of +100.00% and +1.43%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Zimmer Biomet (ZBH) Q1 Earnings and Revenues Top Estimates

Zimmer (ZBH) delivered earnings and revenue surprises of +12.57% and +1.84%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Exagen Inc. (NASDAQ:XGN) Sees Large Decrease in Short Interest

Exagen Inc. (NASDAQ:XGN - Get Free Report) was the recipient of a large decline in short interest in April. As of April 15th, there was short interest totaling 729,740 shares, a decline of 52.5% from...

Exagen Inc. (NASDAQ:XGN) Given Average Recommendation of "Moderate Buy" by Analysts

Exagen Inc. (NASDAQ:XGN - Get Free Report) has been given an average recommendation of "Moderate Buy" by the ten research firms that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating and nine have issued a buy rating on the company. The average 1...

Exagen (NASDAQ:XGN) Cut to "Sell" at Wall Street Zen

Wall Street Zen downgraded shares of Exagen from a "hold" rating to a "sell" rating in a report on Sunday...

$XGN Q2 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of -$0.13 up 38.10% YoY
• Reported revenue of $19.94M up 15.92% YoY
• Exagen Inc. increased its full-year 2026 revenue guidance to a range of $72 million to $75 million, which compares to the company&#39;s previous guidance of $70 million to $73 million.

Stocktwits

Exagen Inc

 Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.13 up 38.10% YoY
• Reported revenue of $19.94M up 15.92% YoY
• Exagen Inc. increased its full-year 2026 revenue guidance to a range of $72 million to $75 million, which compares to the company's previous guidance of $70 million to $73 million.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

$XGN Q1 '26 Earnings Results & Recap

Exagen Inc. expects to incur additional losses in future periods, though existing capital resources are believed sufficient to fund obligations for the next twelve months, with a reversal of cash trend expected in remaining fiscal year quarters.

https://files.quartr.com/streams/2026-08-04/8beb84d3-80d5-4b25-8d15-6640c4c41a25/0/live_transcript.jsonl?ref=U3RvY2t0d2l0cw==

XGN  Earnings Call

Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info